Synthesis of Cross-Conjugated Dendritic Fluorophores
1H NMR (CDCl3) δ 0.88 (t, 24H, J ) 6.6 Hz), 1.2-1.5 (m,
144H), 1.75 (m, 16H), 3.90 (t, 16H, J ) 6.6 Hz), 6.84 (A of ABq,
16H, J ) 8.7 Hz), 6.8-7.1 (m, 20H), 7.40 (B of ABq, 16H, J )
8.7 Hz), 7.4-7.7 (m, 21H). 13C NMR and DEPT (CDCl3) δ 159.0
(C), 139.2 (C), 138.2 (C), 137.2 (C), 134.7 (CH), 133.9 (CH),
129.5 (CH), 129.2 (CH), 128.4 (CH), 128.2 (CH), 127.8 (CH),
127.4 (C), 125.3 (CH), 124.6 (CH), 124.3 (C), 124.1 (C), 123.4
(C), 114.7 (CH), 92.5 (C), 90.5 (C), 88.4 (C), 68.0 (CH2), 31.9
(CH2), 29.7 (CH2), 29.7 (CH2), 29.6 (CH2), 29.5 (CH2), 29.4
(CH2), 29.3 (CH2), 26.1 (CH2), 22.7 (CH2), 14.1 (CH3). MALDI-
TOF (C214H273IO8), m/e 3099.7.
(OC12H25)6G2: reaction time 24 h; purified by column
chromatography (hexanes/CH2Cl2, 9:1) followed by washing
with hot hexanes; pale yellow solid; yield 54%. 1H NMR
(CDCl3) δ 0.88 (t, 18H, J ) 6.9 Hz), 1.2-1.6 (m, 108H), 1.79
(m, 12H), 3.97 (t, 12H, J ) 6.6 Hz), 6.90 (A of ABq, 12H, J )
8.7 Hz), 6.94 (A of ABq, 6H, J ) 16.2 Hz), 7.13 (B of ABq, 6H,
J ) 16.2 Hz), 7.46 (B of ABq, 12H, J ) 9.0 Hz), 7.54 (br s,
9H), 7.72 (s, 3H). 13C NMR (CDCl3) δ 159.1, 138.3, 134.2, 129.6,
129.4, 127.9, 127.9, 125.4, 124.7, 124.1, 123.4, 114.7, 90.7, 87.8,
68.1, 31.9, 29.7, 29.6, 29.6, 29.6, 29.4, 29.4, 29.3, 26.1, 22.7,
14.1. MALDI-TOF (C150H198O6), m/e 2096.6.
(C5H11)16G′4-I: method B; reaction time 12 h; purified by
column chromatography (CCl4) followed by crystallization from
CHCl3/EtOH; pale yellow solid; yield 32%. 1H NMR (CDCl3) δ
0.87 (t, 48H, J ) 6.6 Hz), 1.2-1.4 (m, 64H), 1.5-1.7 (m, 32H),
2.53 (t, 32H, J ) 7.8 Hz), 6.8-7.2 (m, including A of ABq, 52H,
J ) 8.1 Hz), 7.3-7.7 (m, including B of ABq, 77H, J ) 8.1
Hz). 13C NMR (CDCl3) δ 143.5, 143.4, 138.9, 137.3, 137.1,
137.0, 134.7, 133.5, 132.0, 131.6, 129.6, 129.0, 128.4, 127.8,
125.1, 124.1, 123.9, 123.6, 120.2, 95.3, 90.2, 89.9, 88.1, 35.9,
31.5, 30.9, 22.5, 14.1. MALDI-TOF (C326H305I), m/e 4349.9.
(C5H11)6G′2: method B; reaction time 1 h; purified by
column chromatography (hexanes/CH2Cl2, 8:2) followed by
crystallization from CHCl3/EtOH; white solid; yield 86%. 1H
NMR (CDCl3) δ 0.90 (t, 18H, J ) 6.9 Hz), 1.2-1.4 (m, 24H),
1.63 (m, 12H, J ) 7.2 Hz), 2.62 (t, 12H, J ) 7.5 Hz), 7.1-7.2
(m, including A of ABq, 18H, J ) 8.1 Hz), 7.47 (B of ABq, 12H,
J ) 8.1 Hz), 7.59 (m, 6H), 7.66 (br s, 6H). 13C NMR and DEPT
(CDCl3) δ 143.7 (C), 137.7 (C), 137.5 (C), 133.5 (CH), 131.6
(CH), 129.6 (CH), 129.2 (CH), 128.5 (CH), 127.9 (CH), 124.5
(CH), 124.2 (C), 120.1 (C), 90.3 (C), 87.9 (C), 35.9 (CH2), 31.5
(CH2), 30.9 (CH2), 22.5 (CH2), 14.0 (CH3). MS (FAB+), m/e
1406.0 (100), 1004.8 (23), 776.5 (25). HRMS, m/e calcd for
C
108H109 1405.8529, found 1405.8475.
(OC12H25)12G3: method B; reaction time 1 h; purified by
(C5H11 12G′3: reaction time 12 h; purified by column
)
column chromatography (CH2Cl2) followed by washing with
1
chromatography (CCl4) followed by crystallization from EtAcO/
EtOH; pale yellow solid; yield 38%. 1H NMR (CDCl3) δ 0.88
(t, 36H, J ) 6.6 Hz), 1.2-1.4 (m, 48H), 1.5-1.7 (m, 24H), 2.56
(t, 24H, J ) 7.2 Hz), 7.0-7.2 (m, including A of ABq, 36H, J
) 6.8 Hz), 7.42 (B of ABq, 24H, J ) 6.9 Hz), 7.50-7.72 (m,
30H). 13C NMR and DEPT (CDCl3) δ 143.5 (C), 137.5 (C), 137.2
(C), 134.3 (CH), 133.6 (CH), 131.6 (CH), 129.1 (CH), 128.7
(CH), 128.4 (CH), 128.2 (CH), 125.2 (CH), 124.2 (C), 123.9 (C),
123.7 (C), 120.1 (C), 90.3 (C), 88.3 (C), 88.0 (C), 35.9 (CH2),
31.5 (CH2), 30.9 (CH2), 22.5 (CH2), 14.0 (CH3). MALDI-TOF
(C234H222), m/e 3033.6.
hot EtOH; white solid; yield 71%. H NMR (CDCl3) δ 0.88 (t,
36H, J ) 6.6 Hz), 1.2-1.6 (m, 216H), 1.73 (m, 24H), 3.89 (t,
24H, J ) 6.6 Hz), 6.7-7.7 (m, 90H). 13C NMR and DEPT
(CDCl3) δ 158.9 (C), 138.0 (C), 137.5 (C), 137.5 (C), 129.6 (C),
129.4 (CH), 129.0 (CH), 127.8 (CH), 125.3 (CH), 124.5 (CH),
124.1 (C), 123.5 (CH), 114.6 (CH), 90.5 (C), 88.7 (C), 68.0 (CH2),
31.9 (CH2), 29.7 (CH2), 29.7 (CH2), 29.6 (CH2), 29.5 (CH2), 29.4
(CH2), 26.1 (CH2), 22.7 (CH2), 14.1 (CH3). MALDI-TOF
(C318H408O12), m/e 4422.6.
(C5H11)2G′1-CHO: reaction time 7 h; purified by column
chromatography (hexanes/CH2Cl2, 8:2); colorless oil; yield 97%.
1H NMR (CDCl3) δ 0.90 (t, 6H, J ) 6.9 Hz), 1.2-1.4 (m, 8H),
1.55-1.70 (m, 4H), 2.62 (t, 4H, J ) 7.5 Hz), 7.19 (A of ABq,
4H, J ) 8.3 Hz), 7.46 (B of ABq, 4H, J ) 8.3 Hz), 7.89 (t, 1H,
J ) 1.5 Hz), 7.94 (d, 2H, J ) 1.5 Hz), 10.00 (s, 1H). 13C NMR
and DEPT (CDCl3) δ 190.9 (CHO), 144.1 (C), 139.4 (CH), 136.6
(C), 131.6 (CH), 128.6 (CH), 125.1 (C), 119.6 (C), 91.7 (C), 86.6
(C), 35.9 (CH2), 31.4 (CH2), 30.9 (CH2), 22.5 (CH2), 14.0 (CH3).
MS (EI) m/e 446.3 (100), 389.2 (60), 343.1 (11), 332.1 (25), 166.2
(14). HRMS, m/e calcd for C33H34O 446.2610, found 446.2590.
(C5H11)4G′2-I: method B; reaction time 2 h; purified by
crystallization from CHCl3/EtOH; white solid; yield 91%. 1H
NMR (CDCl3) δ 0.90 (t, 12H, J ) 6.6 Hz), 1.20-1.45 (m, 16H),
1.63 (m, 8H, J ) 7.8 Hz), 2.62 (t, 8H, J ) 7.8 Hz), 7.06 (s, 4H),
7.18 (A of ABq, 8H, J ) 8.4 Hz), 7.47 (B of ABq, 8H, J ) 8.4
Hz), 7.56 (br s, 1H), 7.60-7.62 (m, 6H), 7.77 (d, 2H, J ) 1.5
Hz). 13C NMR and DEPT (CDCl3) δ 143.7 (C), 139.3 (C), 137.1
(C), 134.6 (CH), 133.7 (CH), 131.6 (CH), 129.2 (CH), 128.8
(CH), 128.5 (CH), 128.2 (CH), 124.4 (CH), 124.3 (C), 120.0 (C),
95.2 (C), 90.4 (C), 87.8 (C), 35.9 (CH2), 31.5 (CH2), 30.9 (CH2),
22.5 (CH2), 14.0 (CH3). MS (FAB+), m/e 1089.5 (100), 963.6
(11), 686.3 (25). HRMS, m/e calcd for C74H73I 1088.4757, found
1088.4749.
(C5H11)8G′3-CHO: reaction time 24 h; purified by column
chromatography (CCl4) followed by washing with hot EtOH;
further purification was achieved by crystallization from
hexanes; pale yellow solid; yield 41%. 1H NMR (CDCl3) δ 0.89
(t, 24H, J ) 6.6 Hz), 1.20-1.40 (m, 32H), 1.61 (m, 16H, J )
7.5 Hz), 2.60 (t, 16H, J ) 7.8 Hz), 7.1-7.2 (m, including A of
ABq, 24H, J ) 8.4 Hz), 7.46 (B of ABq, 16H, J ) 8.4 Hz), 7.56-
7.62 (m, 18H), 8.00 (t, 1H, J ) 1.5 Hz), 8.02 (d, 2H, J ) 1.5
Hz), 10.02 (s, 1H). 13C NMR and DEPT (CDCl3) δ 190.7
(CHO), 143.7 (C), 139.5 (CH), 137.7 (C), 137.3 (C), 136.7 (C),
133.6 (CH), 132.1 (CH), 131.6 (CH), 130.9 (CH), 129.2 (CH),
129.0 (CH), 128.7 (CH), 128.5 (CH), 125.5 (CH), 124.7 (C),
124.3 (C), 123.4 (C), 120.1 (C), 91.2 (C), 90.4 (C), 87.8 (C), 87.6
(C), 35.9 (CH2), 31.5 (CH2), 30.9 (CH2), 22.5 (CH2), 14.0 (CH3).
MALDI-TOF (C159H150O), m/e 2077.0.
(C5H11)24G′4: method B; reaction time 12 h; purified by
column chromatography (hexanes/CH2Cl2, 8:2) followed by
crystallization from CHCl3/EtOH; pale yellow solid; yield 65%.
1H NMR (CDCl3) δ 0.85 (t, 72H, J ) 6.6 Hz), 1.15-1.40 (m,
96H), 1.40-1.50 (m, 48H), 2.49 (br s, 48H), 6.7-7.7 (m, 192H).
13C NMR (CDCl3) δ 143.2, 137.1, 133.5, 131.6, 128.9, 128.3,
123.9, 120.3, 120.2, 90.1, 89.1, 88.2, 88.1, 35.9, 31.6, 30.8, 22.5,
14.0. MALDI-TOF (C486H456), m/e 6296.6.
Compound 2: reaction time 1 h 30 min; purified by crystal-
lization from EtAcO/EtOH; white solid; yield 97%. 1H NMR
(CDCl3) δ 0.88 (t, 18H, J ) 6.6 Hz), 1.2-1.6 (m, 108H), 1.7-
1.9 (m, 12H), 3.95-4.04 (m, 12H), 6.71 (s, 4H), 6.86 (A of ABq,
2H, J ) 16.2 Hz), 7.02 (B of ABq, 2H, J ) 16.2 Hz), 7.51 (br
s, 1H), 7.72 (d, 2H, J ) 1.2 Hz). 13C NMR and DEPT (CDCl3)
δ 153.3 (C), 139.7 (C), 138.7 (C), 133.8 (CH), 131.9 (C), 130.4
(CH), 125.8 (CH), 123.8 (CH), 105.3 (CH), 95.2 (C), 73.6 (CH2),
69.2 (CH2), 31.9 (CH2), 31.9 (CH2), 30.3 (CH2), 29.8 (CH2), 29.7
(CH2), 29.7 (CH2), 29.7 (CH2), 29.6 (CH2), 29.4 (CH2), 29.4
(CH2), 29.4 (CH2), 26.1 (CH2), 22.7 (CH2), 14.1 (CH3). HRMS,
m/e calcd for C94H162IO6 1514.1416, found 1514.1380.
Compound 3: reaction time 7 h; purified by column chro-
matography (hexanes/CH2Cl2, 7:3); yellow oil; yield 85%. 1H
NMR (CDCl3) δ 0.84-0.88 (m, 54H), 1.2-1.6 (m, 324H), 1.78
(m, 36H), 3.90-4.00 (m, 36H), 6.65 (s, 12H), 6.79 (A of ABq,
6H, J ) 16.2 Hz), 6.86 (B of ABq, 6H, J ) 16.2 Hz), 7.24 (br
s, 6H), 7.39 (br s, 3H), 7.55-7.59 (m, 6H), 7.62-7.66 (m, 6H),
8.08 (s, 3H). 13C NMR and DEPT (CDCl3) δ 153.2 (C), 143.8
(C), 140.1 (C), 138.5 (C), 137.8 (C), 132.8 (CH), 132.2 (C), 129.7
(CH), 129.6 (CH), 129.4 (CH), 128.8 (CH), 128.2 (CH), 127.3
(CH), 126.5 (CH), 124.2 (CH), 123.8 (C), 121.5(C), 105.2 (CH),
92.8 (C), 89.6 (C), 73.5 (CH2), 69.2 (CH2), 31.9 (CH2), 30.4
(CH2), 29.8 (CH2), 29.7 (CH2), 29.7 (CH2), 29.5 (CH2), 29.4
(CH2), 26.2 (CH2), 26.2 (CH2), 22.7 (CH2), 14.1 (CH3). MALDI-
TOF (C312H498O18), m/e 4536.8.
Ackn owledgm en t. Financial support from the Span-
ish DGI (BQU2002-1327) is gratefully acknowledged. J .
J . Org. Chem, Vol. 68, No. 3, 2003 837